Blueberries Medical Corp
CNSX:BBM
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.005
0.02
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Blueberries Medical Corp
Blueberries Medical Corp. engages in the production and distribution of psychoactive and non-psychoactive cannabis by-products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-04-09. The firm is engaged in the cultivation and development of medicinal cannabis and related products. The firm is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.
Blueberries Medical Corp. engages in the production and distribution of psychoactive and non-psychoactive cannabis by-products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-04-09. The firm is engaged in the cultivation and development of medicinal cannabis and related products. The firm is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis.
